These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15990354)

  • 21. Biocomputational strategies for microbial drug target identification.
    Sakharkar KR; Sakharkar MK; Chow VT
    Methods Mol Med; 2008; 142():1-9. PubMed ID: 18437301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invisible genomes: the genomics revolution and patenting practice.
    Bostanci A; Calvert J
    Stud Hist Philos Biol Biomed Sci; 2008 Mar; 39(1):109-19. PubMed ID: 18331958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrating genomics across drug discovery and development.
    Debouck C
    Toxicol Lett; 2009 Apr; 186(1):9-12. PubMed ID: 18930125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The end of the beginning for genomic medicine.
    Bailey D; Zanders E; Dean P
    Nat Biotechnol; 2001 Mar; 19(3):207-9. PubMed ID: 11231543
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug discovery and development in the age of molecular medicine.
    Vallance P; Levick M
    Clin Pharmacol Ther; 2007 Oct; 82(4):363-6. PubMed ID: 17851574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case study: impact of technology investment on lead discovery at Bristol-Myers Squibb, 1998-2006.
    Houston JG; Banks MN; Binnie A; Brenner S; O'Connell J; Petrillo EW
    Drug Discov Today; 2008 Jan; 13(1-2):44-51. PubMed ID: 18190863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opportunities and challenges in the discovery of new central nervous system drugs.
    Krause JE; Chenard BL
    Ann N Y Acad Sci; 2008 Nov; 1144():243-50. PubMed ID: 19076381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-iDT : tool for identification of drug target in bacteria and validation by Mycobacterium tuberculosis.
    Singh NK; Selvam SM; Chakravarthy P
    In Silico Biol; 2006; 6(6):485-93. PubMed ID: 17518759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human metabolic network reconstruction and its impact on drug discovery and development.
    Ma H; Goryanin I
    Drug Discov Today; 2008 May; 13(9-10):402-8. PubMed ID: 18468557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing the impact of genomics on drug discovery and development.
    Crooke ST
    Nat Biotechnol; 1998 May; 16 Suppl():29-30. PubMed ID: 9591260
    [No Abstract]   [Full Text] [Related]  

  • 33. Discovery research: the scientific challenge of finding new antibiotics.
    Livermore DM;
    J Antimicrob Chemother; 2011 Sep; 66(9):1941-4. PubMed ID: 21700626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights for the development of specific kinase inhibitors by targeted structural genomics.
    Fedorov O; Sundström M; Marsden B; Knapp S
    Drug Discov Today; 2007 May; 12(9-10):365-72. PubMed ID: 17467572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anti-intellectual effects of intellectual property.
    Lipinski CA
    Curr Opin Chem Biol; 2006 Aug; 10(4):380-3. PubMed ID: 16829159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical drug development.
    Brodniewicz T; Grynkiewicz G
    Acta Pol Pharm; 2010; 67(6):578-85. PubMed ID: 21229871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial drug discovery--then, now and the genomics future.
    Monaghan RL; Barrett JF
    Biochem Pharmacol; 2006 Mar; 71(7):901-9. PubMed ID: 16494849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug discovery and computational evolutionary analysis.
    Holbrook JD; Sanseau P
    Drug Discov Today; 2007 Oct; 12(19-20):826-32. PubMed ID: 17933683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New approaches to molecular cancer therapeutics.
    Collins I; Workman P
    Nat Chem Biol; 2006 Dec; 2(12):689-700. PubMed ID: 17108987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotype-first screening for the identification of novel drug targets.
    Austen M; Dohrmann C
    Drug Discov Today; 2005 Feb; 10(4):275-82. PubMed ID: 15708746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.